Pediatric Gardner Syndrome Clinical Presentation
- Author: Michael Gilger, MD; Chief Editor: Carmen Cuffari, MD more...
Adequate screening is a necessity to avoid legal action. Patients must be screened properly to prevent development of cancer once the diagnosis of Gardner syndrome is made.
Osteomas of the skull and the mandible are often present as painless bony overgrowths. These can often be detected before the colonic manifestations. Multiple osteomas may be a clue to the physician that Gardner syndrome is present.
Dental abnormalities include supernumerary teeth and odontomas and are typically diagnosed by physical examination of the mouth and teeth. However, they may only be detected on plain radiography.
Multiple epidermal cysts are often present and are another easily visible clue to the physician that colorectal disease may be present as well. They are commonly found on the face, scalp, and arms, but can occur anywhere on the skin surface. These cysts are benign but may pose a cosmetic concern for the patient.
Fibromatosis may present as an abdominal mass that is easily detected by palpation of the abdomen.
Congenital hypertrophy of the retinal pigmented epithelium is easily detectable by slit-lamp examination. It is a flat pigmented lesion on the retina. Oftentimes, they may be present bilaterally. These lesions do not cause clinical problems.
Thyroid carcinoma may present as a painful or painless mass in the thyroid, sometimes palpable on physical examination.
Haggitt RC, Reid BJ. Hereditary gastrointestinal polyposis syndromes. Am J Surg Pathol. 1986 Dec. 10(12):871-87. [Medline].
Wehrli BM, Weiss SW, Yandow S, Coffin CM. Gardner-associated fibromas (GAF) in young patients: a distinct fibrous lesion that identifies unsuspected Gardner syndrome and risk for fibromatosis. Am J Surg Pathol. 2001 May. 25(5):645-51. [Medline].
Lynch HT, Thorson AG, McComb RD, Franklin BA, Tinley ST, Lynch JF. Familial adenomatous polyposis and extracolonic cancer. Dig Dis Sci. 2001 Nov. 46(11):2325-32. [Medline].
Giardiello FM, Offerhaus GJ, Lee DH, Krush AJ, Tersmette AC, Booker SV. Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut. 1993 Oct. 34(10):1394-6. [Medline].
Bienz M. APC. Curr Biol. 2003 Mar 18. 13(6):215-6. [Medline].
Turina M, Pavlik CM, Heinimann K, Behrensmeier F, Simmen HP. Recurrent desmoids determine outcome in patients with Gardner syndrome: a cohort study of three generations of an APC mutation-positive family across 30 years. Int J Colorectal Dis. 2013 Jun. 28(6):865-72. [Medline].
Knudson AG. Two genetic hits (more or less) to cancer. Nat Rev Cancer. 2001 Nov. 1(2):157-62. [Medline].
Huss S, Nehles J, Binot E, Wardelmann E, Mittler J, Kleine MA, et al. ß-catenin (CTNNB1) mutations and clinicopathological features of mesenteric desmoid-type fibromatosis. Histopathology. 2013 Jan. 62(2):294-304. [Medline].
Giardiello FM, Brensinger JD, Petersen GM. AGA technical review on hereditary colorectal cancer and genetic testing. Gastroenterology. 2001 Jul. 121(1):198-213. [Medline].
Offerhaus GJ, Giardiello FM, Krush AJ, Booker SV, Tersmette AC, Kelley NC, et al. The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology. 1992 Jun. 102(6):1980-2. [Medline].
Sturt NJ, Clark SK. Current ideas in desmoid tumours. Fam Cancer. 2006. 5(3):275-85; discussion 287-8. [Medline].
Heiskanen I, Järvinen HJ. Occurrence of desmoid tumours in familial adenomatous polyposis and results of treatment. Int J Colorectal Dis. 1996. 11(4):157-62. [Medline].
Cancer Facts & Figures 2010. American Cancer Society. Available at http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-026238.pdf. Accessed: Jan 2, 2011.
Douma KF, Bleiker EM, Aaronson NK, Cats A, Gerritsma MA, Gundy CM. Long-term compliance with endoscopic surveillance advice for familial adenomatous polyposis (FAP). Colorectal Dis. 2009 Jul 10. [Medline].
Iaquinto G, Fornasarig M, Quaia M, Giardullo N, D'Onofrio V, Iaquinto S, et al. Capsule endoscopy is useful and safe for small-bowel surveillance in familial adenomatous polyposis. Gastrointest Endosc. 2008 Jan. 67(1):61-7. [Medline].
Johnson MD, Mackey R, Brown N, Church J, Burke C, Walsh RM. Outcome based on management for duodenal adenomas: sporadic versus familial disease. J Gastrointest Surg. 2010 Feb. 14(2):229-35. [Medline].
Loccufier A, Vanhulle A, Moreels R, Deruyter L, Legley W. Gardner syndrome and desmoid tumors. Acta Chir Belg. 1993 Sep-Oct. 93(5):230-2. [Medline].
Half E, Arber N. Colon cancer: preventive agents and the present status of chemoprevention. Expert Opin Pharmacother. 2009 Feb. 10(2):211-9. [Medline].
Lynch PM, Ayers GD, Hawk E, Richmond E, Eagle C, Woloj M. The safety and efficacy of celecoxib in children with familial adenomatous polyposis. Am J Gastroenterol. 2010 Jun. 105(6):1437-43. [Medline].
Vasen HF, Möslein G, Alonso A, Aretz S, Bernstein I, Bertario L, et al. Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut. 2008 May. 57(5):704-13. [Medline].
Galiatsatos P, Foulkes WD. Familial adenomatous polyposis. Am J Gastroenterol. 2006 Feb. 101(2):385-98. [Medline].
Miyaki M, Konishi M, Kikuchi-Yanoshita R, Enomoto M, Tanaka K, Takahashi H, et al. Coexistence of somatic and germ-line mutations of APC gene in desmoid tumors from patients with familial adenomatous polyposis. Cancer Res. 1993 Nov 1. 53(21):5079-82. [Medline].
Soravia C, Berk T, McLeod RS, Cohen Z. Desmoid disease in patients with familial adenomatous polyposis. Dis Colon Rectum. 2000 Mar. 43(3):363-9. [Medline].